Evidence map›Paper›PMID 36231044›Full record

ArticleCells2022

Does Disruption of Optic Atrophy-1 (OPA1) Contribute to Cell Death in HL-1 Cardiomyocytes Subjected to Lethal Ischemia-Reperfusion Injury?

Andrew R Kulek, Vishnu V R Undyala, Anthony R Anzell, Sarita Raghunayakula, Lee Ann MacMillan-Crow, Thomas H Sanderson, Karin Przyklenk

Open access · goldAbstract read
In one paragraph

Article in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Andrew R KulekDepartment of Biochemistry, Microbiology and Immunology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Vishnu V R UndyalaDepartment of Physiology, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Anthony R AnzellDepartment of Human Genetics, School of Public Health, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Sarita RaghunayakulaDepartment of Emergency Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Lee Ann MacMillan-CrowDepartment of Pharmacology & Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.ORCID 0000-0002-1715-6402
Thomas H SandersonDepartment of Emergency Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
Karin PrzyklenkClinical Research Institute, Children's Hospital of Michigan & Department of Pediatrics, Central Michigan University, Detroit, MI 48201, USA.ORCID 0000-0002-9602-6349
Central Michigan University · USMichigan Medicine · USUniversity of Arkansas for Medical Sciences · USUniversity of Pittsburgh · USWayne State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Disruption of mitochondrial structure/function is well-recognized to be a determinant of cell death in cardiomyocytes subjected to lethal episodes of ischemia-reperfusion (IR). However, the precise mitochondrial event(s) that precipitate lethal IR injury remain incompletely resolved. Using the in vitro HL-1 cardiomyocyte model, our aims were to establish whether: (1) proteolytic processing of optic atrophy protein-1 (OPA1), the inner mitochondrial membrane protein responsible for maintaining cristae junction integrity, plays a causal, mechanistic role in determining cardiomyocyte fate in cells subjected to lethal IR injury; and (2) preservation of OPA1 may contribute to the well-documented cardioprotection achieved with ischemic preconditioning (IPC) and remote ischemic conditioning. We report that HL-1 cells subjected to 2.5 h of simulated ischemia displayed increased activity of OMA1 (the metalloprotease responsible for proteolytic processing of OPA1) during the initial 45 min following reoxygenation. This was accompanied by processing of mitochondrial OPA1 (i.e., cleavage to yield short-OPA1 peptides) and release of short-OPA1 into the cytosol. However, siRNA-mediated knockdown of OPA1 content did not exacerbate lethal IR injury, and did not attenuate the cardioprotection seen with IPC and a remote preconditioning stimulus, achieved by transfer of 'reperfusate' medium (TRM-IPC) in this cell culture model. Taken together, our results do not support the concept that maintenance of OPA1 integrity plays a mechanistic role in determining cell fate in the HL-1 cardiomyocyte model of lethal IR injury, or that preservation of OPA1 underlies the cardioprotection seen with ischemic conditioning.

Indexed as

Optic AtrophyReperfusion InjuryCell DeathGTP PhosphohydrolasesHumansIschemiaMetalloproteasesMyocytes, CardiacRNA, Small InterferingGTP PhosphohydrolasesMetalloproteasesOPA1 protein, humanRNA, Small Interferingapoptosiscardiomyocyteischemia-reperfusion injuryischemic preconditioningmitochondrial morphosisOMA1 cristae remodelingOPA1remote ischemic conditioning

Identifiers

PMID36231044
PMCPMC9564372
OpenAlexW4303628092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.